Full Author : ['Li, Sheyu', 'Vandvik, Per Olav', 'Lytvyn, Lyubov', 'Guyatt, Gordon H', 'Palmer, Suetonia C', 'Rodriguez-Gutierrez, Rene', 'Foroutan, Farid', 'Agoritsas, Thomas', 'Siemieniuk, Reed A C', 'Walsh, Michael', 'Frere, Lawrie', 'Tunnicliffe, David J', 'Nagler, Evi V', 'Manja, Veena', 'Asvold, Bjorn Olav', 'Jha, Vivekanand', 'Vermandere, Mieke', 'Gariani, Karim', 'Zhao, Qian', 'Ren, Yan', 'Cartwright, Emma Jane', 'Gee, Patrick', 'Wickes, Alan', 'Ferns, Linda', 'Wright, Robin', 'Li, Ling', 'Hao, Qiukui', 'Mustafa, Reem A']
Journal Title : BMJ (Clinical research ed.)
Chapter : Section3
Journal Year : 2021
Cited by : Not Available
CLINICAL QUESTION: What are the benefits and harms of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists when added to usual care (lifestyle interventions and/or other diabetes drugs) in adults with ty.....
